Showing 2,829 results

Filters Content type: News, Editors' picks, About HIV Topic: PrEP

Pre-exposure prophylaxis involves people who do not have HIV taking antiretroviral drugs when they are at risk of exposure to HIV in order to prevent infection. The drugs are usually taken as pills (oral PrEP).

PrEP policies & guidelines

UK: NICE recommends offering PrEP to people at high risk of HIV for first time

Editor's pick
National Institute for Health and Care Excellence (NICE)
17 December 2021
Injectable & long-acting HIV treatment

Merck Announces Clinical Holds on Studies Evaluating Islatravir for the Treatment and Prevention of HIV-1 Infection

Editor's pick
Merck press release
14 December 2021
Vaginal rings & topical PrEP

IPM Statement on US Food and Drug Administration Review of Dapivirine Vaginal Ring

Editor's pick
International Partnership for Microbicides
13 December 2021
Vaginal rings & topical PrEP

WHO continues to support its conditional recommendation for the dapivirine vaginal ring as an additional prevention option for women at substantial risk of HIV

Editor's pick
World Health Organization
13 December 2021
PrEP science

Landscape report launched on novel technologies for the prevention of HIV, STIs, and unwanted pregnancy

Editor's pick
Unitaid
10 December 2021
Injectable & long-acting HIV treatment

Long-Acting HIV Therapy Hits a Snag

Editor's pick
POZ
9 December 2021
PrEP policies & guidelines

CDC: Tell Everyone About HIV PrEP and Don't 'Grill' Patients

Editor's pick
Medscape (requires free registration)
9 December 2021
Adherence

Digital pill tracks HIV prevention pill adherence with 98 percent accuracy

Editor's pick
European Pharmaceutical Review
9 December 2021
PrEP programmes & uptake

Practitioners and policies create barriers to PrEP and HIV testing for young people in sub-Saharan Africa

News
8 December 2021
Pharmaceutical industry

Merck pauses 2 more trials of backbone HIV drug over red flag, raising doubts about multi-pronged R&D strategy

Editor's pick
FierceBiotech
7 December 2021
PrEP science

Merck Announces Pause in Enrollment for Two Phase 3 Clinical Trials of Investigational, Once-Monthly, Oral Islatravir for Pre-Exposure Prophylaxis (PrEP) of HIV-1 infection

Editor's pick
BusinessWire
7 December 2021
PrEP programmes & uptake

Israeli Gays Fought for Subsidy of an anti-HIV Drug. Why Are So Few Using It?

Editor's pick
Haaretz
6 December 2021
PrEP programmes & uptake

Use of HIV prevention treatments is very low among Southern Black gay men

Editor's pick
The Conversation
2 December 2021
Government, leadership & policy

Over £23 million investment to end new HIV infections by 2030

Editor's pick
Department of Health and Social Care
1 December 2021
PrEP programmes & uptake

Kenya: The People Most At Risk of HIV in Kenya Aren't Using Preventive Drugs - We Asked Why

Editor's pick
AllAfrica
29 November 2021
PrEP programmes & uptake

The Long-Term Prognosis of PrEP (video)

Editor's pick
Contagion Live
25 November 2021
PrEP

PrEP for women in Europe webinars: evaluation form

News
19 November 2021
Activism & civil society

A Financial Disaster Hits US HIV Agencies in January. Why Won’t Anyone Stop It?

Editor's pick
My Fabulous Disease
16 November 2021
PrEP policies & guidelines

England: Urgent call for PrEP to be made more widely available

Editor's pick
Terrence Higgins Trust
16 November 2021
PrEP programmes & uptake

Why focusing on family could help increase young people’s PrEP use

Editor's pick
Avert
15 November 2021
Vaginal rings & topical PrEP

In Memory of Zena Stein, Public Health Pioneer, Advocate for Justice

Editor's pick
Columbia University
15 November 2021
HIV testing programmes & uptake

HIV testing and prevention services affected badly by COVID in Europe, HIV treatment less so

News
15 November 2021
Transmission & prevention

aidsmapLIVE: HIV prevention special Video

November 2021
PrEP programmes & uptake

Seasons of risk: the PrEP journey of adolescent girls and young women in Kenya and South Africa

News
8 November 2021